Picture of Rohto Pharmaceutical logo

4527 — Rohto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Rohto - 6-MTH group results

Nov 13 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2019        Sep 30, 2018     Mar 31, 2020 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               90.43               87.26           184.00    
                   (+3.6 pct)          (+11.2 pct)      (+0.2 pct)  
  Operating           10.39               10.71            21.50    
                   (-3.0 pct)          (+23.7 pct)      (+3.3 pct)  
  Recurring           10.88               11.08            21.30    
                   (-1.8 pct)          (+26.6 pct)      (+12.3 pct) 
  Net                  7.31                7.32            13.50    
                   (-0.2 pct)          (+29.6 pct)      (+37.8 pct) 
  EPS               64.07 yen           64.22 yen       118.35 yen  
  EPS Diluted       63.86 yen           63.96 yen                   
  Ann Div                               25.00 yen        26.00 yen  
  -Q2 div           13.00 yen           11.00 yen                   
  -Q4 div                               14.00 yen        13.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T

Recent news on Rohto Pharmaceutical

See all news